Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linhui Wang

Showing results (121-130 of 223) with videos related to

Pageof 23
Sort By:
Journal of Endourology|July 29, 2015
Oncologic and Functional Outcomes of Laparoendoscopic Single-Site Radical Nephrectomy for Localized Kidney Cancer: A Single Surgeon's Series with a Minimum of 3-Year Follow-UpJiwen Cheng, Junming Chen, Xia Sheng, et al.
Frontiers in Public Health|December 8, 2022
A novel thinking: DDR axis refines the classification of ccRCC with distinctive prognosis, multi omics landscape and management strategyAimin Jiang, Jiaao Song, Xiao Fang, et al.
European Journal of Pharmacology|February 22, 2014
Metabolomic evaluation of the response to endocrine therapy in patients with prostate cancerGang Huang, Xinru Liu, Li Jiao, et al.
Urology|August 30, 2014
RCCRT1 is correlated with prognosis and promotes cell migration and invasion in renal cell carcinomaShangqing Song, Zhenjie Wu, Cheng Wang, et al.
Frontiers in Immunology|May 20, 2022
Identification and Verification of m<sup>7</sup>G Modification Patterns and Characterization of Tumor Microenvironment Infiltration <i>via</i> Multi-Omics Analysis in Clear Cell Renal Cell CarcinomaKai Dong, Di Gu, Jiazi Shi, et al.
Frontiers in Immunology|March 14, 2022
Elevated SNRPA1, as a Promising Predictor Reflecting Severe Clinical Outcome <i>via</i> Effecting Tumor Immunity for ccRCC, Is Related to Cell Invasion, Metastasis, and Sunitinib SensitivityAimin Jiang, Jialin Meng, Wenliang Gong, et al.
Cells|February 11, 2023
Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell CarcinomaAimin Jiang, Juelan Ye, Ye Zhou, et al.
International Journal of Biological Sciences|August 23, 2021
DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinomaYewei Bao, Aimin Jiang, Kai Dong, et al.
Medcomm|August 2, 2024
Renal cancer: signaling pathways and advances in targeted therapiesAimin Jiang, Jinxin Li, Ziwei He, et al.
Biomedicines|October 26, 2024
A Multi-Omics Prognostic Model Capturing Tumor Stemness and the Immune Microenvironment in Clear Cell Renal Cell CarcinomaBeibei Xiong, Wenqiang Liu, Ying Liu, et al.
Pageof 23

Showing results (121-130 of 223) with videos related to

Sort By:
Pageof 23
Journal of Endourology|July 29, 2015
Oncologic and Functional Outcomes of Laparoendoscopic Single-Site Radical Nephrectomy for Localized Kidney Cancer: A Single Surgeon's Series with a Minimum of 3-Year Follow-UpJiwen Cheng, Junming Chen, Xia Sheng, et al.
Frontiers in Public Health|December 8, 2022
A novel thinking: DDR axis refines the classification of ccRCC with distinctive prognosis, multi omics landscape and management strategyAimin Jiang, Jiaao Song, Xiao Fang, et al.
European Journal of Pharmacology|February 22, 2014
Metabolomic evaluation of the response to endocrine therapy in patients with prostate cancerGang Huang, Xinru Liu, Li Jiao, et al.
Urology|August 30, 2014
RCCRT1 is correlated with prognosis and promotes cell migration and invasion in renal cell carcinomaShangqing Song, Zhenjie Wu, Cheng Wang, et al.
Frontiers in Immunology|May 20, 2022
Identification and Verification of m<sup>7</sup>G Modification Patterns and Characterization of Tumor Microenvironment Infiltration <i>via</i> Multi-Omics Analysis in Clear Cell Renal Cell CarcinomaKai Dong, Di Gu, Jiazi Shi, et al.
Frontiers in Immunology|March 14, 2022
Elevated SNRPA1, as a Promising Predictor Reflecting Severe Clinical Outcome <i>via</i> Effecting Tumor Immunity for ccRCC, Is Related to Cell Invasion, Metastasis, and Sunitinib SensitivityAimin Jiang, Jialin Meng, Wenliang Gong, et al.
Cells|February 11, 2023
Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell CarcinomaAimin Jiang, Juelan Ye, Ye Zhou, et al.
International Journal of Biological Sciences|August 23, 2021
DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinomaYewei Bao, Aimin Jiang, Kai Dong, et al.
Medcomm|August 2, 2024
Renal cancer: signaling pathways and advances in targeted therapiesAimin Jiang, Jinxin Li, Ziwei He, et al.
Biomedicines|October 26, 2024
A Multi-Omics Prognostic Model Capturing Tumor Stemness and the Immune Microenvironment in Clear Cell Renal Cell CarcinomaBeibei Xiong, Wenqiang Liu, Ying Liu, et al.
Pageof 23